MENU
ACAD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ACADIA Pharmaceuticals (ACAD) Ownership - Who owns ACADIA Pharmaceuticals?

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise to makes a difference for underserved neurological and rare disease communities around the world... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
798
Web
https://www.acadia.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.78B
P/E Ratio
10.00
Total Cash
851.46M
Projected Growth
N/A
Total Debt
50.79M
Revenue
1.1B
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
4.97
Total Debt/Equity
N/A
Revenue/Share
6.40 USD as % of share price
View a ticker or compare two or three
ACAD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals drugs for treatment of central nervous system disorders

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
798
Web
https://www.acadia.com